<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR20">
 <label>20.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Jeanne</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Lallemand-Breitenbach</surname>
    <given-names>V</given-names>
   </name>
   <name>
    <surname>Ferhi</surname>
    <given-names>O</given-names>
   </name>
   <name>
    <surname>Koken</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Le Bras</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Duffort</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Peres</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Berthier</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Soilihi</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Raught</surname>
    <given-names>B</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>PML/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3</article-title>
  <source>Cancer Cell</source>
  <year>2010</year>
  <volume>18</volume>
  <issue>1</issue>
  <fpage>88</fpage>
  <lpage>98</lpage>
  <pub-id pub-id-type="doi">10.1016/j.ccr.2010.06.003</pub-id>
  <?supplied-pmid 20609355?>
  <pub-id pub-id-type="pmid">20609355</pub-id>
 </element-citation>
</ref>
